Tecnis multifocal safe and effective in hyperopia and presbyopia

Article

The Tecnis multifocal intraocular lens (MIOL) is safe and efficacious for refractive lensectomy in hyperopia and presbyopia, according to Frank Goes, Belgium.

The Tecnis multifocal intraocular lens (MIOL) is safe and efficacious for refractive lensectomy in hyperopia and presbyopia, according to Frank Goes, Belgium.

At a private outpatient centre in Antwerp, Belgium, 94 presbyopic hyperopic eyes of 47 subjects were implanted with the Tecnis MIOL. Outcomes were recorded at six months from baseline.

The lens demonstrated two clearly defined focal points and MTF results, independent of pupil size. Uncorrected visual acuity (UCVA) improved from 20/100 preoperatively to 20/23 postoperatively. Best corrected visual acuity (BCVA) improved from 20/25 to 20/20. All but four eyes could read J1 monocular with eventual distance correction and 44 out of the 47 subjects could read J3 at intermediate PC distance (22 inches) with eventual distance correction. No eyes lost any lines of vision and 44 subjects were completely spectacle free. A questionnaire found that the satisfaction degree was either excellent (39 patients; 83%) or good (8 patients; 17%).

Goes concluded that the Tecnis lens is able to offer good visual performance, independent of pupil size, as well as being both safe and efficient in this patient population.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.